Emergent Accounts Payable from 2010 to 2025

EBS Stock  USD 5.50  0.23  4.01%   
Emergent Biosolutions Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount Emergent Biosolutions owes to suppliers or vendors for products or services received but not yet paid for. It represents Emergent Biosolutions' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2004-12-31
Previous Quarter
82.1 M
Current Value
60.9 M
Quarterly Volatility
39.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 114.2 M, Interest Expense of 74.5 M or Total Revenue of 583.9 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.018 or PTB Ratio of 1.0. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
  
Check out the analysis of Emergent Biosolutions Correlation against competitors.
For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Latest Emergent Biosolutions' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Emergent Biosolutions over the last few years. An accounting item on the balance sheet that represents Emergent Biosolutions obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Emergent Biosolutions are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Emergent Biosolutions' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emergent Biosolutions' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Emergent Accounts Payable Regression Statistics

Arithmetic Mean73,608,862
Geometric Mean63,832,377
Coefficient Of Variation53.68
Mean Deviation34,629,745
Median61,897,800
Standard Deviation39,515,051
Sample Variance1561.4T
Range108.6M
R-Value0.36
Mean Square Error1460.5T
R-Squared0.13
Significance0.18
Slope2,957,916
Total Sum of Squares23421.6T

Emergent Accounts Payable History

202561.9 M
202460.9 M
2023112.2 M
2022103.5 M
2021128.9 M
201994.8 M
201880.7 M

About Emergent Biosolutions Financial Statements

Emergent Biosolutions shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable60.9 M61.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.